Keyword Suggestion
Domain Informations
Inhibikase.com lookup results from whois.godaddy.com server:
- Domain created: 2010-03-02T18:19:38Z
- Domain updated: 2025-03-14T20:40:32Z
- Domain expires: 2032-03-02T18:19:38Z 6 Years, 58 Days left
- Website age: 15 Years, 307 Days
- Registrar Domain ID: 1587249482_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS-1011.AWSDNS-62.NET
- NS-1025.AWSDNS-00.ORG
- NS-1907.AWSDNS-46.CO.UK
- NS-424.AWSDNS-53.COM
Network
- inetnum : 54.208.0.0 - 54.209.255.255
- name : AMAZO-ZIAD4
- handle : NET-54-208-0-0-2
- status : Reallocated
- created : 2005-09-29
- changed : 2022-09-30
- desc : For details of this service please see,http://ec2.amazonaws.com
Owner
- organization : Amazon.com, Inc.
- handle : AMAZO-4
- address : Array,Seattle,WA,98108-1226,US
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Timezone: America/New_York
Site Inspections
Port Scanner (IP: 54.208.101.55)
Spam Check (IP: 54.208.101.55)
Recent Searched Sites
› Arespetfood.com (6 seconds ago) / PL
› Hlbqmdl42q73m3q6sulcuep74xqy4u5tnolshkg7np2kxkpinnlq.cdn.ampproject.org (15 seconds ago) / US
› Skipark.sk (5 seconds ago) / CZ
› Tlatsoi.com (2 seconds ago) / DE
› Zte.com.cn (14 seconds ago) / CN
› Cartheorybd.com (3 seconds ago) / US
› Bastropfamilyeyecare.com (1 seconds ago) / US
› Blog.bubblessalons.com (9 seconds ago) / US
› Axha.eu (5 seconds ago) / BE
› Bbs-brinkstrasse.moodle-nds.de (5 seconds ago) / US
› Primisdigital.com (7 seconds ago) / NO
› Zuc.snjq3.ink (15 seconds ago) / SE
› Inhibikase.com (1 seconds ago) / US
› Thecapabilitycompany.com (16 seconds ago) / GB
› Unada.io (1 seconds ago) / US
› Idc.luoca.net (1 seconds ago) / US
› Mail.comune.mobils.com (1 seconds ago) / CA
› Xn--61-8kc3bfr2e.xn--p1ai (4 seconds ago) / DE
› Aoeyewear.com (8 seconds ago) / US
› Your-internet-coach.com (10 seconds ago) / RU
Websites Listing
We found Websites Listing below when search with inhibikase.com on Search Engine
Inhibikase Therapeutics Announces Dosing of First Patient in its …
Web 23 hours ago · Inhibikase is headquartered in Atlanta, Georgia with an office in Lexington, Massachusetts. Social Media Disclaimer Investors and others should note that we …
Inhibikase.comInhibikase Therapeutics Announces Dosing of First Patient …
Web 1 day ago · Inhibikase's multi-therapeutic pipeline has a primary focus on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) …
Marketwatch.comInhibikase Therapeutics, Inc. | LinkedIn
Web Inhibikase Therapeutics, Inc. 412 followers. 1w. Inhibikase has provided an interim update from the dose escalation portion of its ‘501’ bioequivalence study of IkT-001Pro. As of …
Linkedin.com2023-05-16 | NDAQ:IKT | Press Release | Inhibikase ... - Stockhouse
Web May 16, 2023 · Inhibikase is headquartered in Atlanta, Georgia with an office in Lexington, Massachusetts. Social Media Disclaimer Investors and others should note that we …
Stockhouse.comInhibikase Therapeutics Reports First Quarter Financial Results and ...
Web 1 day ago · Inhibikase's multi-therapeutic pipeline has a primary focus on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) …
Prnewswire.comInhibikase Therapeutics, Inc. (IKT) Q1 2023 Earnings Call Transcript
Web 21 hours ago · Inhibikase Therapeutics, Inc. ( NASDAQ: IKT) Q1 2023 Earnings Conference Call May 16, 2023 8:00 AM ET Company Participants Alex Lobo - Stern IR …
Seekingalpha.comInhibikase Therapeutics (@inhibikase) | Twitter
Web Apr 21, 2021 · The latest Tweets from Inhibikase Therapeutics (@inhibikase). Inhibikase (Nasdaq: $IKT) is developing disease …
Twitter.comInhibikase Therapeutics Announces Dosing of First ... - Markets …
Web May 16, 2023 · Inhibikase's multi-therapeutic pipeline has a primary focus on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) …
Markets.businessinsider.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| sijishea.com | namesilo.com | -3 Years, -131 Days |
| tpitexas.com | fastdomain.com | -2 Years, -335 Days |
| ftvbunnies.com | namesilo.com | -3 Years, -299 Days |
| muzgo.net | internet.bs | -3 Years, -227 Days |
| mishkahacademy.com | namecheap.com | -3 Years, -103 Days |
| neecetire.com | godaddy.com | -3 Years, -200 Days |
| asdonline.com | markmonitor.com | -2 Years, -14 Days |
| protokol.com | uniregistry.com | -2 Years, -181 Days |
| fpclex.org | whois.godaddy.com | -2 Years, -277 Days |
| vizmeg.com | godaddy.com | -3 Years, -217 Days |